- Washington Governor Jay Inslee on Friday signed a bill that will overhaul the state's medical marijuana market, reconciling the long unregulated system with the voter-approved recreational pot industry.
SHANGHAI - China's parliament has passed legislation that restricts tobacco advertising in public, strengthening efforts to curb smoking in a country where more than a billion people are smokers or exposed to second-hand smoke.
HONOLULU - Hawaii lawmakers on Friday passed a bill that would raise the legal smoking age statewide to 21, positioning it to become the first state in the country to do so.
- The number of confirmed and presumed HIV cases stemming from abuse of intravenous prescription drugs has increased to 142 in a rural part of southeastern Indiana and more cases are being identified every day, a state health official said on Friday.
NEW YORK - Teva Pharmaceutical Industries' bid for Mylan NV would create a company controlling nearly 25 percent of the U.S. generics market, including drugs in short supply, according to industry experts and a Reuters review of regulatory filings.
ZURICH - Food group Nestle said on Friday its skin health unit Galderma would buy certain, undisclosed assets out of Inneov, a joint venture it had with L'Oreal , in a bid to enter the market for food and drink with potential health benefits.
PARIS - Shares in Innate Pharma surged to a record high on Friday as investors cheered a deal with AstraZeneca to accelerate and broaden development of its immune-boosting anti-cancer medicines that could earn the French firm $1.275 billion.
(Reuters Health) - Despite 2009 recommendations to stop giving women under 50 screening mammograms, the rate of first mammograms occurring at age 40 is on the increase, according to a new study.
(Reuters Health) - Feeling grateful may help heart failure patients heal both physically and emotionally, say U.S. researchers.
LONDON - European regulators have recommended approval of Bristol-Myers Squibb's Opdivo, paving the way for it to become the first of a closely watched group of immune system-boosting cancer medicines to go on sale in Europe.